drugset / Trial / NCT05928728

The COLchicine and Atrial FIBrillation Trial

NCT05928728

Phase 3 Recruiting 500 enrolled Herlev and Gentofte Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study to investigate the effects of colchicine on atrial fibrillation recurrence and vascular and cardiac function in patients with atrial fibrillation.

Timeline

Start
2023-07-03
Primary completion
2026-06-14
Completion
2028-11-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Colchicine Small molecule 0.5 mg

Indications